A Danish company's AI that reads the immune system just won the award they call biotech's Nobel

Helen Tayton-Martin stood in New York's American Museum of Natural History this week holding a first. Her Copenhagen company Evaxion won the 2026 International Prix Galien Award — often called the Nobel Prize of biopharmaceutical research — for AI-Immunology, a platform that uses artificial intelligence to decode the immune system and design new treatments for cancer and infectious disease. No Danish company had won the international award before. The platform's furthest-developed candidate is a personalised cancer vaccine whose three-year trial data, presented last week in Madrid, showed durable responses in people with advanced melanoma.

SDG 9 · Industry, innovation and infrastructure — Mechanism: tech innovation